Prehospital hydroxocobalamin for inhalation injury and cyanide toxicity in the United States - analysis of a database and survey of ems providers.
Annals of Burns and Fire Disasters · 2017-06-30 · Observational study
Abstract
Prehospital use of hydroxocobalamin as an antidote for cyanide toxicity, a serious complication of smoke inhalation, has yet to be universally adopted in the United States though its efficacy and safety have been demonstrated since 2006. The purpose of this study was to characterize practices of prehospital hydroxocobalamin administration via a survey of emergency medical services (EMS) and to report a case series from an EMS database to track use of hydroxocobalamin. The Fire Smoke Coalition Newsletter emailed a voluntary survey to EMS subscribers regarding hydroxocobalamin use. Survey responses were analyzed in addition to survival data from the Smoke Inhalation Treatment Database (SITD), a publically available, self-reported, online database for EMS regarding smoke inhalation patient outcomes. Analysis was compared to current published data from PubMed. The survey had a 14% response rate (284/2000). Only 38% reported prehospital utilization of a hydrogen cyanide antidote with 46% using hydroxocobalamin. 20% of responders reported a formal ALS protocol was in place for hydroxocobalamin use. For the SITD, 12 of 13 (92%) patients who received hydroxocobalamin for suspected inhalation survived. Other studies found a survival rate of 72% and 42% after administration of hydroxocobalamin for smoke inhalation. Prehospital administration of hydroxocobalamin for cyanide toxicity is uncommon in the United States, as evidenced by this analysis, despite well-documented safety and efficacy. Although a small sample, patients who received prehospital hydroxocobalamin had improved survival. This survival rate is significantly greater than those reported previously.
Abstract © the authors or publisher, via PubMed. Reuse and removal
Tags
Antidotes · Cyanide · Hydroxocobalamin · Mortality & survival · Poisoning & substance use
Related articles
- Intravenous Hydroxocobalamin for Cyanide Poisoning From Smoke Inhalation: A Comprehensive Scoping Review. (J Am Coll Emerg Physicians Open, 2026)
- Prehospital administration of hydroxocobalamin for smoke inhalation-associated cyanide poisoning: 8 years of experience in the Paris Fire Brigade. (Clin Toxicol (Phila), 2006)
- Prospective study of hydroxocobalamin for acute cyanide poisoning in smoke inhalation. (Ann Emerg Med, 2007)
- Cyanide poisoning and cardiac disorders: 161 cases. (J Emerg Med, 2010)
- Empiric management of cyanide toxicity associated with smoke inhalation. (Prehosp Disaster Med, 2011)
- Acute cyanide poisoning in prehospital care: new challenges, new tools for intervention. (Prehosp Disaster Med, 2006)